Yangyang Zhang Selected Research

1- methyl- 4- cyclohexyl- 1,2,3,6- tetrahydropyridine

1/2021

Deficiency of cold-inducible RNA-binding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yangyang Zhang Research Topics

Disease

26	Neoplasms (Cancer) 06/2022 - 04/2013
10	Inflammation (Inflammations) 05/2022 - 01/2018
7	Hypoxia (Hypoxemia) 01/2022 - 01/2011
7	Atrial Fibrillation 01/2020 - 07/2008
6	Reperfusion Injury 06/2022 - 03/2016
6	Infections 12/2021 - 01/2019
5	Brain Ischemia (Cerebral Ischemia) 06/2022 - 01/2020
5	Ischemic Stroke 01/2022 - 01/2020
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2022 - 03/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2017
4	COVID-19 01/2022 - 01/2020
4	Myocardial Infarction 01/2020 - 01/2016
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2018
3	Osteoarthritis 11/2021 - 07/2021
3	Virus Diseases (Viral Diseases) 06/2021 - 08/2020
3	Fibrosis (Cirrhosis) 02/2021 - 01/2020
3	Wounds and Injuries (Trauma) 01/2021 - 01/2020
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 07/2017
2	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 09/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2022 - 01/2020
2	Cerebral Infarction 05/2022 - 10/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2022
2	Kidney Calculi (Kidney Stone) 01/2022 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2021 - 04/2021
2	Weight Loss (Weight Reduction) 08/2021 - 08/2020
2	Atherosclerosis 04/2021 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 02/2021 - 05/2018
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 01/2021
2	Nasopharyngeal Carcinoma 01/2021 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 12/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 12/2017
2	Carcinogenesis 11/2020 - 01/2020
2	Esophageal Neoplasms (Esophageal Cancer) 08/2020 - 07/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 01/2019
2	Liposarcoma 01/2020 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 10/2019 - 01/2016
2	Lung Neoplasms (Lung Cancer) 02/2019 - 05/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2018 - 07/2009
2	Carcinoma (Carcinomatosis) 09/2017 - 01/2010
2	Hemorrhage 06/2014 - 03/2014
1	Neuroinflammatory Diseases 01/2022
1	Ulcer 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2010
7	LipidsIBA 01/2020 - 02/2015
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
5	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2011
4	Messenger RNA (mRNA)IBA 05/2022 - 01/2019
4	RNA (Ribonucleic Acid)IBA 07/2021 - 01/2019
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
4	LipopolysaccharidesIBA 08/2020 - 08/2013
3	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 04/2021
3	NAD (NADH)IBA 05/2022 - 01/2022
3	Biological ProductsIBA 05/2022 - 01/2020
3	salicylhydroxamic acid (SHAM)IBA 05/2022 - 01/2020
3	Long Noncoding RNAIBA 01/2022 - 01/2019
3	Circular RNAIBA 11/2021 - 01/2019
3	TitaniumIBA 08/2019 - 10/2018
2	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 01/2018
2	Carrier Proteins (Binding Protein)IBA 01/2022 - 03/2021
2	AntioxidantsIBA 01/2022 - 01/2021
2	NeuropeptidesIBA 01/2022 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2016
2	CytokinesIBA 12/2021 - 01/2020
2	danhongIBA 10/2021 - 01/2020
2	Interferon Type IIBA 06/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 06/2021 - 01/2021
2	Erythropoietin FDA Link 01/2021 - 01/2020
2	Competitive Endogenous RNAIBA 01/2021 - 01/2019
2	EnzymesIBA 01/2021 - 04/2016
2	CholesterolIBA 01/2021 - 01/2020
2	Nimodipine (Modus)FDA LinkGeneric 01/2021 - 01/2020
1	hydroxysafflor yellow AIBA 06/2022
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 06/2022
1	quinone (benzoquinone)IBA 05/2022
1	Oxidoreductases (Dehydrogenase)IBA 05/2022
1	formononetinIBA 05/2022
1	Interleukin-6 (Interleukin 6)IBA 05/2022
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 05/2022
1	Interleukin-18 (Interleukin 18)IBA 05/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	CreatinineIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Inosine FDA Link 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2022

Therapy/Procedure

10	Therapeutics 01/2022 - 07/2008
7	Drug Therapy (Chemotherapy) 11/2021 - 12/2017
6	Radiotherapy 01/2022 - 12/2017
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2021 - 01/2010
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2021
3	Length of Stay 02/2021 - 03/2014
2	Aftercare (After-Treatment) 08/2021 - 10/2018
2	Operative Surgical Procedures 04/2021 - 02/2019
2	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 04/2019 - 07/2017
2	Lasers (Laser) 01/2016 - 01/2014
1	Hemoperfusion 01/2022